Evaluation of bone tissue remodeling and mineral metabolism in elderly patients who have not been previously examined and have received no antiosteoporotic therapy

Objective: to evaluate bone tissue remodeling and mineral metabolism in elderly women who have not been previously examined and have received no antiosteoporotic therapy. Patients and methods. A total of 3152 women aged 65—75 years were examined using questionnaires and tests according to internatio...

Full description

Saved in:
Bibliographic Details
Main Authors: S B Malichenko, Elena Aleksandrovna Mashchenko, E R Shakhnis, M U Shibilova, V S Malichenko
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2012-03-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/398
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850040647504887808
author S B Malichenko
Elena Aleksandrovna Mashchenko
E R Shakhnis
M U Shibilova
V S Malichenko
author_facet S B Malichenko
Elena Aleksandrovna Mashchenko
E R Shakhnis
M U Shibilova
V S Malichenko
author_sort S B Malichenko
collection DOAJ
description Objective: to evaluate bone tissue remodeling and mineral metabolism in elderly women who have not been previously examined and have received no antiosteoporotic therapy. Patients and methods. A total of 3152 women aged 65—75 years were examined using questionnaires and tests according to international validated scales and tests. The investigators measured bone density by dual-energy X-ray absorptiometry and mineral and bone mineral parameters. Results. Most patients were ascertained to have motor and physical impairments and cognitive dysfunction; 100% of cases had risk factors for osteoporosis (OP); 32.4% had a history of atraumatic fractures; 56.4% were diagnosed as having OP during standard examinations; 72.7% needed treatment in accordance with the FRAX procedure. The sensitivity of FRAX in patients (with OP without pathological fractures, OP with a history of low-energy fractures, or osteopenia with pathological fractures) requiring treatment according to these standard methods was 70.3, 71.5, and 24.3%, respectively. Conclusion. The majority of elderly (65—75-year-old) women who had not been previously examined and had received no antiosteoporotic therapy were found to have bone metabolic disturbances, a history of fractures in the presence of cognitive dysfunction, impaired motor activity, lowered quality of life, and inadequate calcium intake. At the same time, FRAX is not always the method of choice.
format Article
id doaj-art-4c526656e6e24fc997db6c55a25e162c
institution DOAJ
issn 1996-7012
2310-158X
language Russian
publishDate 2012-03-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-4c526656e6e24fc997db6c55a25e162c2025-08-20T02:56:02ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2012-03-0161323810.14412/1996-7012-2012-7131703Evaluation of bone tissue remodeling and mineral metabolism in elderly patients who have not been previously examined and have received no antiosteoporotic therapyS B MalichenkoElena Aleksandrovna MashchenkoE R ShakhnisM U ShibilovaV S MalichenkoObjective: to evaluate bone tissue remodeling and mineral metabolism in elderly women who have not been previously examined and have received no antiosteoporotic therapy. Patients and methods. A total of 3152 women aged 65—75 years were examined using questionnaires and tests according to international validated scales and tests. The investigators measured bone density by dual-energy X-ray absorptiometry and mineral and bone mineral parameters. Results. Most patients were ascertained to have motor and physical impairments and cognitive dysfunction; 100% of cases had risk factors for osteoporosis (OP); 32.4% had a history of atraumatic fractures; 56.4% were diagnosed as having OP during standard examinations; 72.7% needed treatment in accordance with the FRAX procedure. The sensitivity of FRAX in patients (with OP without pathological fractures, OP with a history of low-energy fractures, or osteopenia with pathological fractures) requiring treatment according to these standard methods was 70.3, 71.5, and 24.3%, respectively. Conclusion. The majority of elderly (65—75-year-old) women who had not been previously examined and had received no antiosteoporotic therapy were found to have bone metabolic disturbances, a history of fractures in the presence of cognitive dysfunction, impaired motor activity, lowered quality of life, and inadequate calcium intake. At the same time, FRAX is not always the method of choice.https://mrj.ima-press.net/mrj/article/view/398fraxosteoporosisfraxrisk factors for osteoporosis
spellingShingle S B Malichenko
Elena Aleksandrovna Mashchenko
E R Shakhnis
M U Shibilova
V S Malichenko
Evaluation of bone tissue remodeling and mineral metabolism in elderly patients who have not been previously examined and have received no antiosteoporotic therapy
Современная ревматология
frax
osteoporosis
frax
risk factors for osteoporosis
title Evaluation of bone tissue remodeling and mineral metabolism in elderly patients who have not been previously examined and have received no antiosteoporotic therapy
title_full Evaluation of bone tissue remodeling and mineral metabolism in elderly patients who have not been previously examined and have received no antiosteoporotic therapy
title_fullStr Evaluation of bone tissue remodeling and mineral metabolism in elderly patients who have not been previously examined and have received no antiosteoporotic therapy
title_full_unstemmed Evaluation of bone tissue remodeling and mineral metabolism in elderly patients who have not been previously examined and have received no antiosteoporotic therapy
title_short Evaluation of bone tissue remodeling and mineral metabolism in elderly patients who have not been previously examined and have received no antiosteoporotic therapy
title_sort evaluation of bone tissue remodeling and mineral metabolism in elderly patients who have not been previously examined and have received no antiosteoporotic therapy
topic frax
osteoporosis
frax
risk factors for osteoporosis
url https://mrj.ima-press.net/mrj/article/view/398
work_keys_str_mv AT sbmalichenko evaluationofbonetissueremodelingandmineralmetabolisminelderlypatientswhohavenotbeenpreviouslyexaminedandhavereceivednoantiosteoporotictherapy
AT elenaaleksandrovnamashchenko evaluationofbonetissueremodelingandmineralmetabolisminelderlypatientswhohavenotbeenpreviouslyexaminedandhavereceivednoantiosteoporotictherapy
AT ershakhnis evaluationofbonetissueremodelingandmineralmetabolisminelderlypatientswhohavenotbeenpreviouslyexaminedandhavereceivednoantiosteoporotictherapy
AT mushibilova evaluationofbonetissueremodelingandmineralmetabolisminelderlypatientswhohavenotbeenpreviouslyexaminedandhavereceivednoantiosteoporotictherapy
AT vsmalichenko evaluationofbonetissueremodelingandmineralmetabolisminelderlypatientswhohavenotbeenpreviouslyexaminedandhavereceivednoantiosteoporotictherapy